Study Details

Healthy, Non-Smoking Adults Needed

Study Number

8409-184-1

Group

Group 1

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Dec. 09, 2019 - Apr. 20, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Details:

Screening: Nov 12, 13, 14, 15, 18, 19, 20, 21, 22, 25, 26

Check-in: Dec 9

Check-out: Dec 17

Outpatient Visits: Dec 20, 24, 31; Jan 7, 21; Feb 4, 18; Mar 3, 17, 31; Apr 14

Study Number

8409-184-1

Group

Group 1

Gender

both

Age

18-65

Location

Dallas, Texas

Compensation

$7,658

Study Dates

Dec. 09, 2019 - Apr. 20, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

• Healthy Non-Smoking Adults, age 18-65

• BMI (body mass index) 18-30

• Join us for a stay of 8 nights followed by 11 outpatient visits

• Compensation up to $7658 may be provided for time and participation

Details

Details:

Screening: Nov 12, 13, 14, 15, 18, 19, 20, 21, 22, 25, 26

Check-in: Dec 9

Check-out: Dec 17

Outpatient Visits: Dec 20, 24, 31; Jan 7, 21; Feb 4, 18; Mar 3, 17, 31; Apr 14

Calculate Your BMI!

Calculate Your BMI!